OncNGS
  • Home
  • Call for tenders (closed)
  • About OncNGS
  • Phases
    • Pre-commercial Procedure
    • Phase 0 : Curiosity Driven Research
    • Open Market Consultation
    • Phase I : Solution design
    • Phase II: Prototype development
    • Phase III : Clinical validation of a limited set of pre-commercial devices
  • FAQ
  • News
  • Contact
  • Workspace
  • Home
  • Call for tenders (closed)
  • About OncNGS
  • Phases
    • Pre-commercial Procedure
    • Phase 0 : Curiosity Driven Research
    • Open Market Consultation
    • Phase I : Solution design
    • Phase II: Prototype development
    • Phase III : Clinical validation of a limited set of pre-commercial devices
  • FAQ
  • News
  • Contact
  • Workspace

Archive for février, 2023

Update on the current stage of the oncNGS Pre-Commercial Procurement procedure

Update on the current stage of the oncNGS Pre-Commercial Procurement procedure

Read More
The oncNGS consortium selects 4 innovative ideas for the research and development of Next Generation Sequencing solutions for cancer tests

The oncNGS consortium selects 4 innovative ideas for the research and development of Next Generation Sequencing solutions for cancer tests

The eight procurers of the oncNGS consortium, representing healthcare providers from Belgium, Italy, France, Spain and Germany, selected four novel approaches for NGS cancer tests,[…]
Read More

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 874467

Follow us:

© OncNGS

  • Privacy policy
  • Disclaimer